View in EDS HTML Full Text PDF Full Text

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.

Saved in:
Bibliographic Details
Title: Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.
Authors: Vázquez R; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France.; Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia (IIT), Milan, Italy., Riveiro ME; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France., Berenguer-Daizé C; Aix Marseille University, CNRS, INP, Institute of NeuroPhysiopathology, Marseille, France., O'Kane A; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom., Gormley J; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom., Touzelet O; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom., Rezai K; Department of Radio-Pharmacology, Institute Curie-René Huguenin Hospital, Saint-Cloud, France., Bekradda M; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France., Ouafik L; Aix Marseille University, CNRS, INP, Institute of NeuroPhysiopathology, Marseille, France.; APHM, CHU Nord, Service de Transfert d'Oncologie Biologique, Marseille, France.
Source: Frontiers in oncology [Front Oncol] 2021 Jan 06; Vol. 10, pp. 589218. Date of Electronic Publication: 2021 Jan 06 (Print Publication: 2020).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33489885
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vázquez+R%22">Vázquez R</searchLink>; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France.; Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia (IIT), Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Riveiro+ME%22">Riveiro ME</searchLink>; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France.<br /><searchLink fieldCode="AU" term="%22Berenguer-Daizé+C%22">Berenguer-Daizé C</searchLink>; Aix Marseille University, CNRS, INP, Institute of NeuroPhysiopathology, Marseille, France.<br /><searchLink fieldCode="AU" term="%22O'Kane+A%22">O'Kane A</searchLink>; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gormley+J%22">Gormley J</searchLink>; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Touzelet+O%22">Touzelet O</searchLink>; Discovery and Scientific Affairs Department, Fusion Antibodies plc., Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rezai+K%22">Rezai K</searchLink>; Department of Radio-Pharmacology, Institute Curie-René Huguenin Hospital, Saint-Cloud, France.<br /><searchLink fieldCode="AU" term="%22Bekradda+M%22">Bekradda M</searchLink>; Preclinical Department, Early Drug Development Group (E2DG), Boulogne-Billancourt, France.<br /><searchLink fieldCode="AU" term="%22Ouafik+L%22">Ouafik L</searchLink>; Aix Marseille University, CNRS, INP, Institute of NeuroPhysiopathology, Marseille, France.; APHM, CHU Nord, Service de Transfert d'Oncologie Biologique, Marseille, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2021 Jan 06; Vol. 10, pp. 589218. <i>Date of Electronic Publication: </i>2021 Jan 06 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33489885
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2020.589218
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 589218
    Titles:
      – TitleFull: Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vázquez R
      – PersonEntity:
          Name:
            NameFull: Riveiro ME
      – PersonEntity:
          Name:
            NameFull: Berenguer-Daizé C
      – PersonEntity:
          Name:
            NameFull: O'Kane A
      – PersonEntity:
          Name:
            NameFull: Gormley J
      – PersonEntity:
          Name:
            NameFull: Touzelet O
      – PersonEntity:
          Name:
            NameFull: Rezai K
      – PersonEntity:
          Name:
            NameFull: Bekradda M
      – PersonEntity:
          Name:
            NameFull: Ouafik L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 01
              Text: 2021 Jan 06
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 10
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1